The Bright Side of Biologic Stability: A Thermofluor Screen for Rational Buffer Optimisation
Learn about the challenges of stabilising injectable biologics.
PR
Upperton wins Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025
Upperton wins the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025.
Upperton Pharma Solutions Awarded VaxHub Sustainable Grant to Advance Oral Vaccine Delivery in Partnership with the University of Oxford’s Pandemic Sciences Institute
Upperton will apply its expertise to enable the next generation of Adenovirus-vectored vaccines to be delivered without needles.
Project Management Spotlight with Sophie Skinner
Discover more about our team. In this Spotlight, meet our Project Coordinator, Sophie Skinner, on her journey with Upperton.
Upperton Shortlisted for Two Categories at the Pharma Industry Awards UK 2025
We’re delighted to have been shortlisted in two major categories at the Pharma Industry Awards UK 2025, recognising our growth.
Biologics vs Small Molecules: Key Considerations in Drug Development
How the body absorbs, distributes, metabolizes, and excretes a drug – differs significantly between the two modalities.
CDMO Services for Finished Dosage Forms (FDF): Formulation, Development, and Manufacturing
Discover how CDMO services support Finished Dosage Form (FDF) development, from formulation to manufacturing and regulatory compliance.
Upperton Pharma Solutions Wins Business Expansion Award at the 2025 Pharmaceutical Technology Excellence Awards
We’re delighted to announce that we’ve won the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.
Product Considerations in Sterile Drug Formulation Development
Discover the critical product decisions in sterile drug formulation development. Learn how planning with your CDMO can streamline your path.
Why Project Management Is the Real Differentiator for CDMOs
Discover why project management is the critical success factor for CDMO collaborations. Explore Upperton’s approach.